Lifecore Biomedical Inc (LFCR)
5.85
+0.08
(+1.39%)
USD |
NASDAQ |
May 17, 16:00
5.85
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Cash from Investing (TTM): -4.153M for May 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
May 31, 2023 | -4.811M |
February 28, 2023 | -15.46M |
November 30, 2022 | 43.74M |
August 31, 2022 | 41.90M |
May 31, 2022 | 79.96M |
February 28, 2022 | 84.96M |
November 30, 2021 | 15.38M |
August 31, 2021 | 25.73M |
May 31, 2021 | -12.31M |
February 28, 2021 | -3.064M |
November 30, 2020 | -2.774M |
August 31, 2020 | -13.99M |
May 31, 2020 | -23.89M |
February 29, 2020 | -23.75M |
November 30, 2019 | -94.04M |
August 31, 2019 | -92.03M |
May 31, 2019 | -96.80M |
February 28, 2019 | -105.22M |
November 30, 2018 | -42.52M |
August 31, 2018 | -43.16M |
May 31, 2018 | -35.59M |
February 28, 2018 | -38.75M |
November 30, 2017 | -32.16M |
August 31, 2017 | -30.17M |
May 31, 2017 | -25.42M |
Date | Value |
---|---|
February 28, 2017 | -22.95M |
November 30, 2016 | -29.18M |
August 31, 2016 | -39.14M |
May 31, 2016 | -40.42M |
February 29, 2016 | -34.04M |
November 30, 2015 | -25.27M |
August 31, 2015 | -22.74M |
May 31, 2015 | -34.44M |
February 28, 2015 | -31.97M |
November 30, 2014 | -32.34M |
August 31, 2014 | -24.34M |
May 31, 2014 | -13.34M |
February 28, 2014 | -10.74M |
November 30, 2013 | -11.32M |
August 31, 2013 | -11.73M |
May 31, 2013 | -10.42M |
February 28, 2013 | -51.54M |
November 30, 2012 | -50.16M |
August 31, 2012 | -41.31M |
May 31, 2012 | -44.07M |
February 29, 2012 | 0.961M |
November 30, 2011 | -5.919M |
August 31, 2011 | -12.79M |
May 31, 2011 | -29.39M |
February 28, 2011 | -29.57M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-96.80M
Minimum
May 2019
84.96M
Maximum
Feb 2022
-5.367M
Average
-4.811M
Median
May 2023
Cash from Investing (TTM) Benchmarks
Aquestive Therapeutics Inc | -1.022M |
SELLAS Life Sciences Group Inc | -- |
ADMA Biologics Inc | -5.398M |
Relmada Therapeutics Inc | 20.51M |
Jaguar Health Inc | -- |